TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/26/22 18:26 | 5/24/22 | GNCA | Genocea Biosciences, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | New Enterprise Associates 16, L.P. | MD | T | S.m | -751 | 0.0723 | 0 | -10,377 | -100 | 0 | D | |||||||||||||||
4/13/22 17:00 | 4/11/22 | TRVI | Trevi Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | New Enterprise Associates 16, L.P. | MD | T | P | 5,000 | 1.90 | 0 | 2,632 | 34 | 10,421 | D | |||||||||||||||
12/27/21 16:40 | 12/10/21 | MTCR | Metacrine, Inc. | DE | Health | Drug | Pharmaceutical Preparations | New Enterprise Associates 16, L.P. | MD | T | S.m | -494 | 0.9944 | 0 | -497 | -16 | 2,563 | D | |||||||||||||||
10/19/21 21:09 | 10/18/21 | TRVI | Trevi Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | New Enterprise Associates 16, L.P. | MD | T | P.d | 0 | 0.00 | 0 | 1,852 | 31 | 7,790 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |